Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 6,705,028,400
  • Market Capitalization, $K 6,705,028
  • Shares Outstanding, K 65,050
  • 60-Month Beta 1.39
  • Price/Earnings ttm 20.87
  • Annual Dividend & Yield 0.15 (0.15%)
  • Most Recent Dividend 0.071 on 09/24/19
  • Management Fee 0.47%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
96.03 +6.50%
on 10/02/19
105.98 -3.50%
on 09/20/19
-2.17 (-2.08%)
since 09/18/19
3-Month
96.03 +6.50%
on 10/02/19
108.13 -5.42%
on 08/01/19
-4.18 (-3.93%)
since 07/18/19
52-Week
89.01 +14.90%
on 12/24/18
116.25 -12.03%
on 03/04/19
-10.73 (-9.50%)
since 10/18/18

Most Recent Stories

More News
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 48.61 (-0.94%)
IBB : 102.27 (-0.74%)
XBI : 78.65 (-1.21%)
CELG : 102.95 (+1.13%)
GILD : 64.91 (-0.49%)
BIIB : 220.06 (-2.46%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 48.61 (-0.94%)
IBB : 102.27 (-0.74%)
XBI : 78.65 (-1.21%)
INCY : 77.76 (+0.43%)
VRTX : 176.23 (-0.84%)
AMGN : 202.72 (-0.41%)
Amgen to Buy Celgene's Otezla: 5 ETF Drugs

Amgen agreed to buy psoriasis and psoriatic arthritis drug Otezla from Celgene for $13.4 billion in cash.

NVS : 86.88 (-0.40%)
BMY : 53.03 (+1.16%)
BBH : 120.96 (-0.15%)
PJP : 57.34 (-0.78%)
IBB : 102.27 (-0.74%)
PBE : 48.61 (-0.94%)
CELG : 102.95 (+1.13%)
AMGN : 202.72 (-0.41%)
IEIH : 24.65 (-0.73%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 48.61 (-0.94%)
IBB : 102.27 (-0.74%)
XBI : 78.65 (-1.21%)
TECH : 200.25 (-0.62%)
AMGN : 202.72 (-0.41%)
BIIB : 220.06 (-2.46%)
Biotech ETFs in Focus on Impressive Q2 Earnings Results

Let's take a look at some ETFs with wide exposure to a few biotechnological companies which released solid Q2 earnings results recently.

IBB : 102.27 (-0.74%)
FBT : 125.63 (-0.46%)
BBH : 120.96 (-0.15%)
XBI : 78.65 (-1.21%)
GILD : 64.91 (-0.49%)
ALXN : 98.41 (-1.58%)
AMGN : 202.72 (-0.41%)
BIIB : 220.06 (-2.46%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 48.61 (-0.94%)
IBB : 102.27 (-0.74%)
XBI : 78.65 (-1.21%)
TECH : 200.25 (-0.62%)
INCY : 77.76 (+0.43%)
AMGN : 202.72 (-0.41%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

PBE : 48.61 (-0.94%)
IBB : 102.27 (-0.74%)
XBI : 78.65 (-1.21%)
QGEN : 28.49 (+1.10%)
CELG : 102.95 (+1.13%)
ILMN : 309.44 (-0.36%)
Biotech ETFs in Focus on String of Q1 Earnings Beats

Let's take a sneak peek at some ETFs having high exposure to some impactful biotechnological companies on the release of Q1 earnings results.

FBT : 125.63 (-0.46%)
BBH : 120.96 (-0.15%)
IBB : 102.27 (-0.74%)
BIB : 44.80 (-1.47%)
BIIB : 220.06 (-2.46%)
AMGN : 202.72 (-0.41%)
ALXN : 98.41 (-1.58%)
GILD : 64.91 (-0.49%)
Biotech ETFs in Focus on String of Q1 Earnings Beats

Let's take a sneak peek at some ETFs having high exposure to some impactful biotechnological companies on the release of Q1 earnings results.

FBT : 125.63 (-0.46%)
BBH : 120.96 (-0.15%)
IBB : 102.27 (-0.74%)
BIB : 44.80 (-1.47%)
BIIB : 220.06 (-2.46%)
AMGN : 202.72 (-0.41%)
ALXN : 98.41 (-1.58%)
GILD : 64.91 (-0.49%)
Will Biotech ETFs Continue to Rally in Q1 Earnings?

Here we study the possible impact of some major Q1 earnings releases on certain biotech ETFs .

FBT : 125.63 (-0.46%)
BBH : 120.96 (-0.15%)
BIB : 44.80 (-1.47%)
IBB : 102.27 (-0.74%)
GILD : 64.91 (-0.49%)
ALXN : 98.41 (-1.58%)
AMGN : 202.72 (-0.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade IBB with:

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

2nd Resistance Point 104.36
1st Resistance Point 103.32
Last Price 102.27
1st Support Level 101.36
2nd Support Level 100.44

See More

52-Week High 116.25
Fibonacci 61.8% 105.84
Fibonacci 50% 102.63
Last Price 102.27
Fibonacci 38.2% 99.42
52-Week Low 89.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar